Whenever Congress or state legislatures start talking about capping high drug costs or other legislative solutions, pharmaceutical companies argue that these laws are counterproductive. They argue that they must charge exorbitant prices for new drugs because it pays for the next class of cures.
Recently, RazorMetrics was brought in to be evaluated on our hard numbers: time to ROI, actual savings, and real prescriber response stats. When we pulled
I am an optimist. I gravitate toward stories that are heartwarming and inspirational. If you’re like me, then you likely experienced COVID news as an
Google’s Controversial Ascension Jan. 6, 2020 The recent controversy over Ascension’s contract with Google is not surprising and should be seen as a teachable moment.
And, we are waiting…
Contact us, and we will be more than happy to answer all of your questions.
